CANDIDEMIA
Clinical trials for CANDIDEMIA explained in plain language.
Never miss a new study
Get alerted when new CANDIDEMIA trials appear
Sign up with your email to follow new studies for CANDIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope against deadly superbug fungus: experimental drug shows promise
Disease control CompletedThis study tested an experimental drug called APX001 in 9 adults with bloodstream or deep-organ infections caused by the drug-resistant fungus Candida auris. Participants had few or no other treatment options. The goal was to see if the drug could clear the infection and keep pat…
Matched conditions: CANDIDEMIA
Phase: PHASE2 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope against Drug-Resistant fungal infections?
Disease control CompletedThis study tested a new antifungal drug called APX001 in 21 adults with a serious bloodstream fungal infection (candidemia), including cases where standard treatments might not work. Participants received the drug for up to 14 days, with possible extra treatment afterward. The go…
Matched conditions: CANDIDEMIA
Phase: PHASE2 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New blood tests could speed up fungal infection diagnosis
Diagnosis CompletedThis study looked at whether combining several blood tests can detect serious fungal infections (candidemia) faster and more accurately than standard methods. Researchers tested 2 adult hospital patients with suspected fungal infections using a panel of biomarkers and DNA tests. …
Matched conditions: CANDIDEMIA
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Diagnosis
Last updated May 20, 2026 11:53 UTC
-
New blood test may speed up fungal infection diagnosis
Diagnosis CompletedThis study looked at a blood test called the Wako Beta-D-glucan test to see how well it can detect serious fungal infections in people with weak immune systems. Researchers tested 280 patients and checked how often two positive results within 15 days meant a real infection. The g…
Matched conditions: CANDIDEMIA
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated May 18, 2026 12:00 UTC
-
New drug shows promise in preventing deadly fungal infections after transplant
Prevention CompletedThis study tested a new medicine called rezafungin to see if it can prevent serious fungal infections in adults getting a bone marrow transplant. About 600 participants received either rezafungin or the standard treatment. The goal was to see if rezafungin works better at keeping…
Matched conditions: CANDIDEMIA
Phase: PHASE3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated May 26, 2026 09:20 UTC